One-half of these patients had type 1 diabetes (18/1285) and the other half had type 2 diabetes (18/90)
Replicative capacity of beta-cells and type 1 diabetes
Currently, research on GLP-1 agonists during pregnancy is limited, and most guidelines recommend against their use while pregnant due to potential unknown effects on fetal development
Week 1: Right thigh, upper-outer quadrant Week 2: Left thigh, upper-outer quadrant Week 3: Right thigh, lower-front quadrant Week 4: Left thigh, lower-front quadrant Week 5: Right thigh, upper-front quadrant Week 6: Left thigh, upper-front quadrant Week 7: Right thigh, lower-outer quadrant Week 8: Left thigh, lower-outer quadrant After eight weeks, the cycle restarts
Recent studies have also explored the ocular risks associated with GLP-1 therapies
R., & Diaz, E